androgen synthesis inhibitorの例文
- The androgen synthesis inhibitors aminoglutethimide and ketoconazole were first marketed in 1960 and 1977, respectively, and the newer drug abiraterone acetate was introduced in 2011.
- The earlier androgen synthesis inhibitors aminoglutethimide and ketoconazole have only limitedly been used in the treatment of prostate cancer due to toxicity concerns and have been replaced by abiraterone acetate.
- An example is the steroidal antiandrogen cyproterone acetate, which is both a potent AR antagonist and a potent progestogen and hence antigonadotropin, as well as a weak androgen synthesis inhibitor.
- The most common methods of androgen deprivation therapy currently employed to treat prostate cancer are castration ( with a GnRH analogue or orchiectomy ), non-steroidal antiandrogens, and the androgen synthesis inhibitor abiraterone acetate.
- Although the term " antiandrogen " is generally used to refer specifically to AR antagonists, it may also be used to describe " functional " antiandrogens like androgen synthesis inhibitors and antigonadotropins, including even estrogens and progestogens.